High-affinity antibodies and long-lived memory B cells are the hallmarks of the humoral response. Activated B cells undergo affinity maturation and differentiation in the germinal center (GC), dependent upon signals provided by CD4^+^ follicular helper T (T~FH~) cells^[@R1]^, including interleukin 21 (IL-21) and costimulatory molecules such as CD40L (CD40 ligand) ^[@R2]-[@R5]^. The signals provided by T~FH~ cells include cytokines shared by other T~H~ cell subsets, such as IL-4 and interferon-γ (IFN-γ), which promote B cell isotype switching appropriate to pathogen challenge ^[@R3],[@R6]-[@R8]^. T~FH~ cell-derived IL-21 is a key regulator of the GC as, in its absence, B cells display defects in affinity maturation and generation of long-lived plasma cells ^[@R4],[@R5]^. IL-4 also promotes the GC response as mice deficient in this cytokine or its high affinity receptor IL-4Rα have compromised immunoglobulin IgG1 and IgE responses ^[@R7],[@R9],[@R10]^, and its deletion results in defective GC B cell expansion ^[@R7]^. IL-4 secretion, together with CD40-CD40L signaling, enables T~FH~ cells to induce the enzyme activation-induced cytidine deaminase (AID) in B cells, necessary for class switch recombination (CSR) and Ig affinity maturation ^[@R6],[@R11]^. The interplay of IL-21 and IL-4 signals shapes the humoral response, with IL-21-deficiency in mice resulting in increased IL-4-driven IgE switching, with their combined deficiency leading to an impairment in GC formation and antibody responses that exceeds that of either alone ^[@R12],[@R13]^.

Interactive engagement between T~FH~ cells and GC B cells entails repeated short-lived cellular contacts ^[@R14]^. Chronological accumulation of T cell-derived signals results in the development of B cells expressing high affinity Ig receptors ^[@R15]^, and their differentiation into antibody secreting cells (ASCs) ^[@R16]^. Conversely, repetitive cognate T-GC B cell interactions result in TCR-dependent changes in Ca^+^ and in cytokine expression in T cells ^[@R17]^, with B cell-derived ICOS signals promoting proper positioning of T~FH~ cells within the B cell follicle and GC ^[@R18]^ and upregulation of CD40L on T~FH~ cells ^[@R19]^, necessary for GC B cell selection ^[@R20]^.

Here we show that as a consequence of T-B cell interactions, T~FH~ cell function evolved during the GC response, with these changes critical for B cell maturation. T~FH~ cells differentiated from an IL-21^+^ T~FH~ population observed proximally to the GC dark zone, the site of Ig gene hypermutation, early after immune challenge to an IL-4^+^ T~FH~ cell population robustly expressing CD40L that developed later and resided more distal to the dark zone. Modulation of the T~FH~ cell phenotype within the GC was dependent upon cell division and occurred in concert with alterations in gene expression. These distinct T~FH~ cell populations were responsible for unique effects on B cell maturation, with the IL-21^+^ T~FH~ cells enabling selection of high-affinity clones and IL-4^+^ T~FH~ cells facilitating differentiation of antibody-secreting plasma cells. Thus, after entering the GC, T~FH~ cells undergo progressive maturation to regulate GC B cell differentiation.

RESULTS {#S1}
=======

IL-4 and IL-21 expression define three populations of T~FH~ cells {#S2}
-----------------------------------------------------------------

Disruption of signaling by either IL-21 or IL-4 results in defective humoral responses ^[@R4],[@R5],[@R7],[@R12],[@R21]^. The non-redundant functions of IL-21 or IL-4 ^[@R22]^ suggest that T~FH~ cells producing these cytokines are discrete, differing in their ability to regulate GC B cells. To explore this possibility, we generated C57BL/6 (B6) bicistronic *Il21*-*IRES-Katuska* (Kat) reporter mice (*Il21*^Kat/+^) to investigate the kinetics of IL-21 expression in T~FH~ cells^[@R17]^. We immunized IL-21^Kat/+^ mice intraperitoneally (i.p.) with sheep red blood cells (SRBCs)^[@R23]^. The percentage of T~FH~ cells expanded following immunization (**[Supplementary Fig. 1a](#SD1){ref-type="supplementary-material"}**), with *Il21*-Kat expression largely restricted to the follicle and absent from sites of nascent T~FH~ cell-DC interactions ^[@R24]^ in the T cell zone **([Supplementary Fig. 1b](#SD1){ref-type="supplementary-material"}**), suggesting that initial cytokine expression depended upon B cell interactions. The number of *Il21*-Kat^+^ T~FH~ cells within the GC increased through day 12 (**[Supplementary Fig. 1c](#SD1){ref-type="supplementary-material"}**), indicating that T~FH~ cells acquire expression of IL-21 after entering the GC or that a *Il21*-Kat^+^ T~FH~ cell population entered the GC and displaced the *Il21*-Kat^−^ T~FH~ cells.

We next crossed *Il21*^Kat/+^ to *Il4*-*IRES*-GFP (*Il4*^GFP/+;^ 4get) mice ^[@R25]^ to obtain *Il21*^Kat/+^*Il4*^GFP/+^ double reporter mice^[@R17]^ and examined *Il21*-Kat and *Il4*-GFP expression during T~FH~ cell development. We subcutaneously (s.c.) infected *Il21*^Kat/+^*Il4*^GFP/+^ mice with the helminth *Nippostrongylus brasiliensis*, which induces IL-4 production in T~FH~ cells ^[@R26]^. We assessed *Il21*-Kat and *Il4*-GFP expression in splenic CD4^+^CD44^hi^CXCR5^hi^PD-1^hi^ T~FH~ and CD4^+^CD44^hi^CXCR5^lo^PD-1^lo^ T~H~2 cells, as well as in a CD4^+^CD44^hi^CXCR5^int^PD-1^int^ population (**[Fig. 1a](#F1){ref-type="fig"}**), a mixture of central memory T cells, T~H~2 and pre-T~FH~ cells ^[@R27]^. Three days post-parasite challenge, we detected small numbers of splenic *Il21*-Kat^+^, *Il21*-Kat^+^*Il4*-GFP^+^ double positive and *Il4*-GFP^+^ T~FH~ cells (**[Fig. 1b](#F1){ref-type="fig"}**), and a fourth population that was *Il21*-Kat^−^*Il4*-GFP^−^ double negative. From days 3 to 5, the total number of T~FH~ cells rose, driven by expansion of the *Il21*-Kat^+^ and *Il21*-Kat^+^*Il4*-GFP^+^ pools (**[Fig. 1b,c](#F1){ref-type="fig"}**). From day 5, *Il21*-Kat^+^ T~FH~ cells decreased, while *Il4*-GFP^+^ T~FH~ cells increased, becoming dominant by day 15, at which point the *Il21*-Kat^+^*Il4*-GFP^+^ double positive population had also receded (**[Fig. 1b](#F1){ref-type="fig"}**). All three populations were present in the GC at days 7-8 (**[Fig. 1b,d](#F1){ref-type="fig"}**). By contrast, beginning at day 3, and extending to day 15 post-infection, T~H~2 cells were *Il21*-Kat^−^*Il4*-GFP^+^ as expected (**[Fig. 1b](#F1){ref-type="fig"}**). The latter cells arose by day 3 and showed a gradual loss of *Il21*-Kat^+^ cells by day 15.

The immune response to *N. brasiliensis* begins in lymph nodes (LNs) of the mediastinum, followed by those in the mesentery, and then the spleen ^[@R28]^. In the mediastinal LNs of *Il21*^Kat/+^*Il4*^GFP/+^ infected mice, the earliest T~FH~ cells appeared at day 2 and were mostly *Il21*-Kat^+^; by days 3 and 5 most T~FH~ cells were *Il21*-Kat^+^*Il4*-GFP^+^ double positive (**[Supplementary Fig. 2a](#SD1){ref-type="supplementary-material"}**). In the mesenteric nodes of infected *Il21*^Kat/+^*Il4*^GFP/+^ mice, T~FH~ cells were *Il21*-Kat^+^ by day 3, followed by a shift towards *Il4*-GFP^+^ T~FH~ cells by day 8 (**[Supplementary Fig. 2b](#SD1){ref-type="supplementary-material"}**), analogous to the spleen. Because we could detect GC B cells in the mediastinal and mesenteric LNs of uninfected mice (**[Supplementary Fig. 2c](#SD1){ref-type="supplementary-material"}**), presumably due to environmental antigen exposure ^[@R29]^, we focused the remainder of our experiments on splenic responses to minimize background.

We next assessed the cell division-dependent expression of *Il21* and *Il4* following transfer of CellTrace Violet® dye labeled ovalbumin (OVA)-specific Thy1.2^+^CD4^+^OT-II TCR transgenic T cells from *Il21*^Kat/+^*Il4*^GFP/+^ mice into congenic Thy1.1^+^ recipient mice. One day following cell transfer recipients were s.c. infected with *N. brasiliensis* combined with 4-hydroxy-3-nitrophenylacetyl-OVA (NP-OVA), followed by a single intravenous (i.v.) injection of NP-OVA two days post-infection, to ensure Ag persistence and enable tracking of Ag-specific T and B cells. *Il21*-Kat expression in the Thy1.1^+^CD4^+^CD44^hi^CXCR5^hi^PD-1^hi^ transferred T~FH~ cells was detected by the third division, while *Il4*-GFP expression was seen beginning at the fifth division, and occurred in cells that were also *Il21*-Kat^+^ (**[Fig. 1e](#F1){ref-type="fig"}**). Three days following *N. brasiliensis* plus NP-OVA injection we found *Il21*-Kat expressing Thy1.1^+^CD4^+^CD44^hi^CXCR5^hi^PD-1^hi^ T~FH~ cells without significant expression of *Il4*-GFP (**[Supplementary Fig. 3](#SD1){ref-type="supplementary-material"})**. These results suggest that cytokine transcript expression in T~FH~ cells occurred in a progressive manner, with *Il21*-Kat appearing first at day 3, followed by *Il4*-GFP five days post-infection, after which *Il21*-Kat expression was gradually lost with *Il4*-GFP expression maintained to day 15.

We next sought to address the secretion of IL-4 and IL-21 proteins in reporter expressing T~FH~ cells following *N. brasiliensis* infection. Although we detected three T~FH~ cell populations expressing *Il4* and *Il21* mRNA between days 5 and 8 during our initial time-course experiment, intracellular cytokine staining after *ex vivo* stimulation with phorbol 12-myristate 13-acetate and ionomycin at these time points indicated that T~FH~ cells primarily produced either IL-4 or IL-21 (**[Supplementary Fig. 4a](#SD1){ref-type="supplementary-material"}**). Similar observations were made after i.p. immunization of wild type mice with NP-keyhole limpet hemocyanin (NP-KLH) in alum (**[Supplementary Fig. 4b,c](#SD1){ref-type="supplementary-material"}**). Using a dual-color ELISPOT assay we detected IL-21 or IL-4 protein secretion by individual splenic T~FH~ cells isolated from *Il21*^Kat/+^*Il4*^GFP/+^ mice 8 days following *N. brasiliensis* infection (**[Fig. 1f](#F1){ref-type="fig"}**). While ELISPOT assays only detected a relatively small number of IL-21^+^ and IL-4^+^ T~FH~ cells, as noted by others ^[@R30]^, analysis of *Il21*-Kat^+^, *Il21*-Kat^+^*Il4*-GFP^+^, and *Il4*-GFP^+^ sorted splenic T~FH~ cells revealed a strong correlation between reporter expression and cytokine secretion, with *Il21*-Kat^+^ T~FH~ cells producing IL-21 and *Il4*-GFP^+^ T~FH~ cells producing IL-4, substantiating fidelity of the reporters, with the majority of T~FH~ cells secreting only one or the other cytokine (**[Fig. 1f](#F1){ref-type="fig"}**). By contrast, relatively few T~FH~ cells co-secreted IL-21 and IL-4. Thus, we designated the *Il21*-Kat^+^ cells as T~FH~21 and *Il4*-GFP^+^ cells as T~FH~4 cells. We found that the *Il21*-Kat^+^ *Il4*-GFP^+^ double positive T~FH~ cells produced either IL-21 or IL-4 in ELISPOTs, rarely both, suggesting that secretion of these cytokines by T~FH~ cells is largely exclusive (**[Fig. 1f](#F1){ref-type="fig"} and [Supplementary Fig. 4a,c](#SD1){ref-type="supplementary-material"}**); thus, we designated the dual-reporter expressing *Il21*-Kat^+^*Il4*-GFP^+^ T~FH~ cells as T~FH~21+4. Collectively, these results supported the idea that cytokine expression and secretion in T~FH~ cells change over the course of an infection.

T~FH~21 and T~FH~4 cell populations are transcriptionally distinct {#S3}
------------------------------------------------------------------

To determine if the three cytokine-expressing CD4^+^CD44^hi^CXCR5^hi^PD-1^hi^ T~FH~ cell populations were transcriptionally distinct, we infected *Il21*^Kat/+^*Il4*^GFP/+^ mice with *N. brasiliensis* and sorted splenic *Il21*-Kat^+^, *Il21*-Kat^+^*Il4*-GFP^+^, and *Il4*-GFP^+^ T~FH~ cells, as well as *Il4*-GFP^+^ T~H~2 cells at day 8 post infection (**[Supplementary Fig. 5a](#SD1){ref-type="supplementary-material"}**). Using RNA sequencing, a total of six pairwise comparisons were made between the aforementioned four populations, resulting in 1300 genes that were differentially expressed (FDR q-value \< 0.05) in at least one of the pairwise comparisons, with T~H~2 cells the most different compared to each population of T~FH~ cells (**[Fig. 2a](#F2){ref-type="fig"} and [Supplementary Fig. 5b](#SD1){ref-type="supplementary-material"}**). The T~FH~21 and T~FH~21+4 groups were most alike, while T~FH~4 cells shared similarities with the T~FH~21+4 and the T~H~2 populations (**[Fig. 2a](#F2){ref-type="fig"} and [Supplementary Fig. 5b](#SD1){ref-type="supplementary-material"}**). Clustering analysis assigned each differentially expressed gene to one of four groups (**[Fig. 2a](#F2){ref-type="fig"} and [Supplementary Fig. 5c](#SD1){ref-type="supplementary-material"}**), representing modules of *Il21*-coregulated genes, *Il4*-coregulated genes, T~FH~-defining genes including *Sh2d1a* and *Batf*, and non-T~FH~ effector genes such as *Il2ra* and *Tbx21*. To analyze the transcriptional differences among the three T~FH~ cell populations, we examined a curated set of genes previously described to be up- or down-regulated in T~FH~ cells compared to other CD4^+^ T^H^ subsets ^[@R31]-[@R33]^. The T~FH~ cell-associated transcription factor genes *Batf* and *Ascl2* ^[@R33],[@R34]^ were upregulated in T~FH~21 and T~FH~21+4 cells compared to T~FH~4 cells, while expression of the chemokine receptor gene *Cxcr4* was higher in T~FH~ cells expressing *Il21*-Kat compared to other two T~FH~ cell populations (**[Fig. 2b,c](#F2){ref-type="fig"}**). Expression of *Cxcr5* and *Pdcd1* was highest in T~FH~21+4 cells confirmed by flow cytometry staining of CXCR5 and PD-1 (**[Fig. 2d](#F2){ref-type="fig"}**). Thus, T~FH~21, T~FH~21+4 and T~FH~4 cells were transcriptionally distinct from one other.

T~FH~21 and T~FH~4 cells differentially localize in the GC {#S4}
----------------------------------------------------------

CXCR4 is necessary for B cell migration between the light and dark zones (LZ and DZ) of the GC ^[@R35]^, and differences in its expression could affect the ability of T~FH~ cells to interact with centrocytes and centroblasts, respectively ^[@R20]^. Consistent with our transcriptome analysis, at day 8 following *N. brasiliensis* infection, T~FH~4 cells had significantly less surface expression of CXCR4 than T~FH~21 and T~FH~21+4 cells (**[Fig. 3a](#F3){ref-type="fig"}**), in agreement with its upregulation by Ascl2 ^[@R34]^ in the latter two (**[Fig. 2c](#F2){ref-type="fig"}**). Based upon this observation, we tested whether the T~FH~ cell populations localized to different regions of the GC. Staining of splenic sections of *Il21*^Kat/+^*Il4*^GFP/+^ mice with CD35 detected follicular dendritic cells that mark the GC LZ ^[@R36]^ (**[Fig. 3b](#F3){ref-type="fig"}**). When measuring the distance from the centers of the DZ to the T~FH~ cells of each type in that GC we observed that T~FH~21 cells were located on average more proximal to the DZ than T~FH~4 cells, and that T~FH~21 cells migrated more efficiently than T~FH~4 cells to the CXCR4 ligand CXCL12 in the dark zone, consistent with their increased CXCR4 expression, while T~FH~21 and T~FH~4 migrated similarly to the control chemokine CXCL13 (**[Fig. 3c](#F3){ref-type="fig"}**) ^[@R36]^. In contrast, cell-surface expression of CD40L ^[@R37]^, which, in combination with IL-4, promotes IgG1 switching and regulates GC B cell differentiation via CD40 signaling ^[@R2],[@R38]^, was significantly enhanced on T~FH~4 and T~FH~4+21 cells compared to T~FH~21 cells at day 8 after *N. brasiliensis* infection (**[Fig. 3d](#F3){ref-type="fig"}**). Thus, T~FH~4 cells expressed increased CD40L and localized more distal to the LZ of the GC than T~FH~21 cells.

T~FH~21 cells become IL-4 producers upon helminth challenge {#S5}
-----------------------------------------------------------

We next used an adoptive-transfer model to assess the effect of T~FH~21, T~FH~21+4 and T~FH~4 cells on the humoral immune response. Previous studies have shown that following adoptive transfer, CD4^+^ T cells maintain expression of either *Il21* or *Il4* for 7 to 10 days ^[@R6],[@R39]^. T~FH~21, T~FH~4+21 or T~FH~4 cells were sorted from Thy1.2^+^ *Il21*Kat^/+^*Il4*^GFP/+^ mice 8 days following *N. brasiliensis* infection and 300,000 cells from each group were transferred into Thy1.1^+^ B6 recipients bearing an irrelevant TCR transgene specific for the GP66-77 epitope of lymphocytic choriomeningitis virus (LCMV; Smarta TCR transgenics; Stg). Recipients of cell transfers were then re-infected and spleens were harvested 13 days after the secondary infection. Following transfer and re-exposure to *N. brasiliensis* we examined cytokine reporter expression by flow cytometry and protein expression by ELISPOT assays in Thy1.2^+^CD4^+^CXCR5^hi^PD-1^hi^ T~FH~ cells (**[Supplementary Fig. 6a](#SD1){ref-type="supplementary-material"}**). At 13 days post-secondary infection approximately 15% of the transferred *Il21*-Kat^+^ T~FH~ cells retained sole expression of this transcript, while about 50% acquired *Il4*-GFP expression (**[Fig. 4a,b](#F4){ref-type="fig"}**). Approximately 40% of the transferred *Il21*-Kat^+^*Il4*-GFP^+^ double positive T~FH~ cells became *Il4*-GFP-expressing T~FH~4 cells, while about 10-15% retained expression of both *Il21*-Kat and *Il4*-GFP (**[Fig. 4a,b](#F4){ref-type="fig"}**). By contrast, virtually all of the transferred *Il4*-GFP^+^ T~FH~ cells that were reporter positive were *Il4*-GFP^+^, with around 15% also upregulating *II21*-Kat (**[Fig. 4a,b](#F4){ref-type="fig"}**). Transferred *Il21*-Kat^−^ *Il4*-GFP^−^ double negative T~FH~ cells did not acquire expression of either cytokine at the day 13 time-point (data not shown). Transferred *Il4*-GFP^+^ expressing cells were localized more distal to the DZ compared to the *Il21*-Kat^+^ cells (**[Supplementary Fig. 6b](#SD1){ref-type="supplementary-material"}**), consistent with their higher CXCR4 expression. Transferred T~FH~ cell subsets maintained their surface phenotype post-transfer, albeit with fewer donor T~FH~4 than T~FH~21 and T~FH~21+4 cells in recipient spleens (**[Supplementary Fig. 6c-e](#SD1){ref-type="supplementary-material"}**). Approximately 10% of the transferred T~H~2 cells were able to acquire T~FH~ cell markers, though this resulted in fewer total T~FH~ cells than when T~FH~21 or T~FH~21+4 were transferred ^[@R17]^ (**[Supplementary Fig. 6d](#SD1){ref-type="supplementary-material"}**). In a like manner, donor T~FH~ cells was maintained similar phenotypes when examined at 7 days following transfer (**[Supplementary Fig. 6f-h](#SD1){ref-type="supplementary-material"}**).

We sorted each of the three T~FH~ cell populations at 13 days post transfer and determined their IL-21 and IL-4 production by dual color ELISPOT assays. Progeny of transferred *Il21*-Kat^+^ T~FH~ cells contained both IL-21 and IL-4 secretors with rare cells secreting both (**[Fig. 4c](#F4){ref-type="fig"})**. Transferred *Il21*-Kat^+^*Il4*-GFP^+^ double positive T~FH~ cells robustly became IL-4-secreting cells, while transferred *Il4*-GFP^+^ T~FH~ cells retained the IL-4 single-positive phenotype (**[Fig. 4c](#F4){ref-type="fig"}**). There was a strong correlation between cytokine reporter expression and protein secretion in all transferred T~FH~ cells, as well as a near-absence of cells secreting IL-21 and IL-4 simultaneously (**[Fig. 4c](#F4){ref-type="fig"}**).

To determine if T~FH~ cells isolated at an early time point following pathogen challenge exhibited similar kinetics of cytokine expression, we modified our transfer model (**[Supplementary Fig. 6a](#SD1){ref-type="supplementary-material"}**) to obtain *Il21*-Kat^+^ and *Il21*-Kat^+^*Il4*-GFP^+^ T~FH~ cells from five days post-infection with *N. brasiliensis* instead of day 8. There were insufficient splenic T~FH~4 cells to transfer at this time point, precluding their analysis (**[Fig. 5a](#F5){ref-type="fig"}**). *Il21*-Kat^+^ and *Il21*-Kat^+^*Il4*-GFP^+^ T~FH~ cells isolated from infected donors at day 5 maintained CXCR5 and PD-1 expression in recipients after adoptive transfer (**[Fig. 5b,c](#F5){ref-type="fig"}**). However, in contrast to *Il21*-Kat^+^ cells isolated 8 days after infection, which largely remained *Il21*-Kat^+^ after transfer, 40% of such cells isolated at day 5 post-infection converted into *Il4*-GFP^+^ expressers following transfer (**[Fig. 5d](#F5){ref-type="fig"}**). Collectively, these data indicate a model of progressive differentiation of T~FH~ cells from *Il21*-Kat-expressing cells to *Il4*-GFP-expressing cells.

T~FH~21 cells and T~FH~4 cells differentially regulate GC responses {#S6}
-------------------------------------------------------------------

We next tested the idea that T~FH~ cell populations with differential expression of IL-21, IL-4, CD40L and CXCR4 contribute to distinctive GC B cell responses. We transferred 300,000 T~FH~21, T~FH~4+21 or T~FH~4 cells sorted from Thy1.2^+^ *Il21*^Kat/+^*Il4*^GFP/+^ mice 8 days following *N. brasiliensis* infection into Thy1.1^+^ Stg B6 recipients, with the latter re-infected and spleens harvested 13 days after the secondary infection, a time point coinciding with the peak of the GC response. Mice that received T~FH~ cells had a significant increase in the percentages and numbers of B220^+^IgD^−^CD95^hi^GL-7^hi^ splenic GC B cells compared to *N. brasiliensis*-infected mice that were not recipients of adoptively transferred cells, with those receiving T~FH~21+4 cells showing the greatest increase in percentages and numbers of GC B cells and average GC size, compared to recipients of T~FH~21 or T~FH~4 cells (**[Fig. 6a,b](#F6){ref-type="fig"})**. This suggested that even though the T~FH~21+4 cell population consisted of T~FH~ cells that secreted either IL-4 or IL-21, they functioned synergistically in promoting the GC response, as predicted by *in vitro* experiments ^[@R40]^.

Compared to T~FH~21 cells, adoptively transferred T~FH~21+4 and T~FH~4 cells promoted IgG1 synthesis by GC B cells, with transferred T~FH~21+4 cells inducing the greatest numbers of IgG1^+^ GC B cells (**[Fig. 6c](#F6){ref-type="fig"}**). Additionally, IgG1 production by GC B cells in mice into which we adoptively transferred IL-4^−/−^ and IL-4^+/+^ T~FH~21 cells were similar (**[Supplementary Fig. 7a](#SD1){ref-type="supplementary-material"}**), suggesting that the minimal amount of IL-4 produced by T~FH~21 cells had a negligible effect upon IgG1 synthesis, as expected. Moreover, adoptively transferred T~FH~21+4 and T~FH~4 cells drove more splenic ASCs to secrete IgG1 and IgE than T~FH~21 cells (**[Fig. 6d](#F6){ref-type="fig"} and [Supplementary Fig. 7b](#SD1){ref-type="supplementary-material"}**), consistent with their increased expression of IL-4 (**[Fig. 4d](#F4){ref-type="fig"}**) and CD40L (**[Fig. 3d](#F3){ref-type="fig"}**) ^[@R38],[@R41]^. T~FH~21+4 cells also promoted the development of more B220^lo^CD138^+^ plasma cells than did T~FH~21 cells (**[Supplementary Fig. 7c](#SD1){ref-type="supplementary-material"}**). Using an ELISA specific for *N. brasiliensis* antigens, we found no difference in the amounts of serum IgM, but significantly higher amounts of IgG1 in recipients of T~FH~21+4 and T~FH~4 cells than in mice transferred with T~FH~21 cells, and a trend toward increased IgE production (**[Fig. 6e](#F6){ref-type="fig"})**. The differences in B cell and plasma cell phenotypes in recipient mice were not the result of enhanced proliferation or diminished B cell apoptosis, because BrdU uptake in GC B cells was similar among mice transferred will all the T~FH~ cell subsets (**[Supplementary Fig. 7d](#SD1){ref-type="supplementary-material"}**), while caspase 3 activity was similar in mice that received T~FH~21 or T~FH~4 cells (**[Supplementary Fig. 7e](#SD1){ref-type="supplementary-material"})**.

To assess the quality of Ag-specific GC B cells generated by the T~FH~ cell subsets, we adoptively transferred T~FH~21, T~FH~21+4 and T~FH~4 cells isolated from Thy1.2^+^*Il21*^Kat/+^*Il4*^GFP/+^ OT-II TCR transgenic mice at day 8 post *N. brasiliensis* infection into Stg B6 recipients. Upon transfer, these mice were infected with *N. brasiliensis* and serially administered NP-OVA (**[Supplementary Fig. 7f](#SD1){ref-type="supplementary-material"}**). Thirteen days post infection we then sequenced the *Vh186.2* gene in splenic GC B cells isolated from host mice, in order to determine the occurrence of the high-affinity tryptophan to leucine point mutation at position 33 (W33L) of the V~H~186.2 Ig heavy chain ^[@R42]^. Although GC B cells from all three recipient groups had a similar overall frequency of mutations in their *Vh186.2* genes (**[Fig. 7b](#F7){ref-type="fig"}**), the W33L point mutation occurred significantly more often in GC B cells taken from recipients of T~FH~21 cells compared to T~FH~4 cells (**[Fig. 7c](#F7){ref-type="fig"}**), indicating that T~FH~21 cells positively promote selection, rather than merely somatic mutation. While transferred T~FH~21 cells promoted the formation of fewer low- as well as high-affinity anti-NP ASCs than did T~FH~21+4 and T~FH~4 cells (**[Fig. 7d](#F7){ref-type="fig"}**), this was likely due to impairment in CSR **([Fig. 6c-e](#F6){ref-type="fig"} and [Supplementary Fig. 7a,b](#SD1){ref-type="supplementary-material"}**) rather than in affinity maturation. Conversely, recipients of T~FH~21+4 and T~FH~4 cells, which had fewer GC B cell clones with mutations that confer increased affinity for NP, had higher numbers of high-affinity anti-NP IgG1 and IgE ASCs than recipients of T~FH~21 cells (**[Fig. 6d](#F6){ref-type="fig"} and [Supplementary Fig. 7b](#SD1){ref-type="supplementary-material"})**, a finding consistent with their enhanced promotion of IgG1- and IgE-secreting ASCs. Although transferred T~FH~21 cells had differentiated into T~FH~21+4 and T~FH~4 cells and began producing IL-4 over the 13 day course of the experiment (**[Fig. 4d](#F4){ref-type="fig"}**), they were not able to induce the phenotypic changes in GC B cells expected of IL-4^+^ T~FH~ cells, such as class-switching to IgG1 (**[Fig. 6c](#F6){ref-type="fig"})**, potentially due to the insufficient or delayed onset of IL-4 production (**[Supplementary Fig. 7a](#SD1){ref-type="supplementary-material"}**).

In addition, GC B cells in mice transferred with T~FH~21 and T~FH~21+4 cells expressed significantly more Bcl-6 than those receiving T~FH~4 cells (**[Fig. 7e](#F7){ref-type="fig"}**). In contrast, expression of *Prdm1*, the gene that encodes Blimp-1, was higher in GC B cells from mice transferred with T~FH~21+4 and T~FH~4 cells compared to those that received T~FH~21 cells **([Fig. 7f](#F7){ref-type="fig"}**), a finding consistent with the decrease in Ig secretion in ASCs isolated from the latter. Thus, GC B cells in mice that received T~FH~21 cells had higher affinity mutations, increased Bcl6 but decreased Ig secretion compared to mice, which received T~FH~21+4 and T~FH~4 cells.

DISCUSSION {#S7}
==========

We propose a model of T~FH~ cell cytokine production in type 2 immune responses, in which discrete populations of IL-21^+^ T~FH~21 and IL-4^+^ T~FH~4 cells play unique roles in determining the antibody response \-- B cell selection and antibody secretion, respectively, with T~FH~21 cells developing into T~FH~4 cells after exposure to antigen presented by GC B cells. In support of this model, previous work using *Il21*^Kat/+^*Il4*^GFP/+^ mice demonstrated that highly Ag-loaded GC B cells interact with T~FH~ cells to promote TCR signaling and result in changes in T~FH~ cell expression from *Il21*-Kat to *Il4*-GFP expression over the course of several hours ^[@R17]^. Here we show that these transient TCR signals are mirrored by durable changes in transcriptional program, localization and surface ligand presentation that occur over several days.

One important difference between the T~FH~21 and T~FH~4 cell transcriptional programs seemed to be migratory regulation. GC B cells deficient in CXCR4 fail to localize to the DZ, resulting in decreased rates of somatic mutation compared to CXCR4-sufficient cells ^[@R36]^. GC B cells that more robustly engage Ag, enabling its presentation to T~FH~ cells, reside longer in the DZ than the LZ, acquiring more Ig gene mutations with increased Ag affinity ^[@R20]^. Our results suggest that T~FH~ cells were not evenly distributed within the GC; rather, those cells nearest the DZ were enriched for T~FH~21 cells, which efficiently select high-affinity mutant B cells. CXCR4^hi^ centroblasts lose CXCR4 and migrate out into the light zone ^[@R43]^. In a like manner, T~FH~4 cells that developed later in the course of the helminth-induced GC response had diminished CXCR4 expression with decreased ability to migrate efficiently to CXCL12.

Our results support the critical role of T~FH~-cell derived IL-21 in an effective humoral response ^[@R4],[@R5],[@R12]^. In its absence, such as in mice receiving transfers of T~FH~4 cells, GC B cells expressed less Bcl-6, and generated fewer CD138^+^ plasma cells, while showing a trend in reduction of antigen-specific ASCs and serum helminth-specific IgG1 compared to recipients of T~FH~21+4 cells, in which both cytokines were present. These data demonstrated that T~FH~21 and T~FH~21+4 cells are essential sources of IL-21, which is required for the maintenance of Bcl-6 expression in GC B cells, GC longevity and production of plasma cells ^[@R4],[@R5]^.

While IL-21 is necessary factor, T~FH~21 cells on their own were not fully capable of orchestrating a productive humoral response, concordant with observations that IL-21 expression is not sufficient for ASC formation ^[@R4],[@R5],[@R22]^. T~FH~21 cells were not able to mobilize high levels of CD40L, a molecule that is critical for class-switching ^[@R44]^ and plasma cell differentiation ^[@R38]^, and also mediates Bcl-6 transcription ^[@R45],[@R46]^. Furthermore, compared to T~FH~4 cells, T~FH~21 cells failed to induce the expression of *Prdm1* (Blimp-1) in GC B cells, which is critical for plasma cell development ^[@R2],[@R44],[@R47],[@R48]^, and is antagonized by Bcl-6 ^[@R49]^. GC B cells from recipients of T~FH~21+4 cells shared traits with those from the T~FH~21 group, such as more frequent high-affinity mutations and increased Bcl6 expression, and the T~FH~4 group, including increased IgG1 and *Prdm1* expression, but had reduced apoptosis compared either group of single-cytokine producers, highlighting significant synergy between IL-21 and IL-4 in promoting GC responses ^[@R12],[@R40]^.

We have shown that T~FH~ cells mature phenotypically and transcriptionally over the course of the GC response. These cells exist as discrete subsets, which progressively differentiate with modulation of cytokine production ^[@R17]^ and of their localization and surface ligand expression to fine-tune the GC reaction.

METHODS {#S8}
=======

Mice {#S9}
----

Mice were housed in pathogen-free conditions at the Yale School of Medicine (New Haven, CT). C57BL/6J (B6), C.129-*Il4^tm1Lky^*/J (4get), B6.PL-*Thy1^a^*/CyJ (Thy1.1) B6.SJL-*Ptprc^a^Pep3^b^*/BoyJ (CD45.1), and B6.Cg-Tg(TcraTcrb)425Cbn/J (OT-II) B6.*Il4^tm1Nnt^*/J animals were purchased from The Jackson Laboratory. B6.Tg(TcrLCMV)1Aox (Smarta; Stg) mice^[@R50]^ were bred in-house. To examine the expression of *Il21* in T~FH~ cells, we generated B6 bicistronic *Il21*-*IRES-Katuska* (Kat)reporter (*Il21*^Kat/+^) mice ^[@R17]^. All animals were used at 6-8 weeks of age, with approval for all procedures given by The Institutional Animal Care and Use Committee of Yale University.

*N. brasiliensis* Infection and Detection of Serum Antibodies {#S10}
-------------------------------------------------------------

Mice were injected s.c. at the base of the tail with third-stage larvae of *N. brasiliensis* (500 viable third-stage larvae/mouse) in 0.2 mL sterile PBS with 1X gentamicin (Gibco). Animals were sacrificed at time points described in the text. Antibody ELISAs for detecting anti-L5 serum antibodies were performed as previously described ^[@R21]^; briefly, stage 5 adult worms (L5) were isolated from intestines of mice infected with L3 larvae 7 days earlier and homogenized. Five micrograms of lysates were used to coat microtiter plates, which were then incubated with sera, followed by anti-mouse IgG1 and IgE secondary antibodies (**[Supplementary Table 2](#SD2){ref-type="supplementary-material"}**).

Cell Transfers and Immunizations {#S11}
--------------------------------

2 × 10^5^ T~FH~ or T~H~2 cells, sorted by flow cytometry, or 5 × 10^5^ CD4^+^ ovalbumin (OVA)-specific OTII TCR transgenic T cells, were transferred to recipient mice via retro-orbital injection. Cells were labeled with CellTrace™ Violet dye according to the protocol provided by the manufacturer (Life Technologies). In certain experiments, mice were immunized i.p. with 10% SRBC (Colorado Serum) (**[Supplementary Fig. 1](#SD1){ref-type="supplementary-material"}**) or 100μg NP~14~-KLH (Biosearch Technologies) emulsified in alum (**[Supplementary Fig. 4b,c](#SD1){ref-type="supplementary-material"}**). In others, mice were injected with 100 μg NP~15~-OVA (Biosearch Technologies) mixed with *N. brasiliensis* (400 third-stage larvae/mouse) s.c. 24 hours post-transfer of cells (**[Fig. 1e](#F1){ref-type="fig"}, [Fig. 7](#F7){ref-type="fig"}, and [Supplementary Fig. 3](#SD1){ref-type="supplementary-material"}**). Mice subsequently received an additional 100μg NP~15~-OVA in PBS every 48 hours by i.v. injection for up to 10 days. Animals were sacrificed at different time points post infection and harvested spleens were processed for flow cytometry.

RNA and cDNA Synthesis {#S12}
----------------------

Sorted cell populations were processed for RNA isolation and conversion into cDNA as described previously ^[@R51]^. RNA from sorted cells was extracted and purified with RNeasy Mini kit (Qiagen), according to the manufacturer\'s instructions. RNA purity was verified by OD 260:280 and OD 260:230 ratio analysis on a NanoDrop® ND-1000 Spectrophotometer (Thermo Scientific). cDNA was synthesized with the iScript™ cDNA Synthesis kit (Bio-Rad) according to the manufacturer\'s instructions.

Quantitative PCR {#S13}
----------------

Real-Time PCR was set up using Brilliant II SYBR Green Master Mix™ and performed on an MX4005P Thermal Cycler™ according to manufacturer\'s protocols (Agilent Technologies), using primers as noted (**[Supplementary Table 1](#SD2){ref-type="supplementary-material"}**). Expression was calculated with the ΔΔxp method normalized to *Hprt*, and all measurements were performed in triplicate.

Flow Cytometry and Cell Sorting {#S14}
-------------------------------

Tissues were homogenized by crushing with the head of a 1mL syringe in a petri dish followed by straining through a 40μm nylon filter. ACK buffer was used for red cell lysis and remaining cells were counted. Antibodies used for flow cytometry staining are listed in **[Supplementary Table 2](#SD2){ref-type="supplementary-material"}**. BrdU was administered to recipient mice (1.5 mg BrdU) i.p. 4 h prior to sacrifice or added daily (0.8mg/mL) in 20% sucrose drinking water for 7 days. Isolated splenocytes were stained using the BrdU staining kit (BD Biosciences) following the manufacturer\'s protocol. Staining for caspase 3 was performed using Caspase 3 staining kit (AAT Bioquest, Inc) following the manufacturer\'s protocol. Staining for CXCR5 was performed at room temperature (25°C) with 30 min incubation. Gates for T~FH~ cells (CXCR5 and PD-1) were determined in all instances based upon staining of these markers in CD44^lo^ naïve CD4 T cells; *i.e*., the top of the CXCR5 and PD-1 gates for naïve T cells were set as the bottom of that for T~FH~ cells. Intracellular staining for cytokines was performed using Cytofix/Cytoperm™ kits (BD Biosciences) following the manufacturer\'s protocol. Stained and rinsed cells were analyzed using an LSRII Multilaser Cytometer (BD Biosciences). For experiments requiring sorting, CD4^+^ T cells were enriched using a biotin-based magnetic separation kit (EasySep™, StemCell Technologies) prior to cell surface staining, with specific populations sorted using a FACSAria™ (BD Biosciences). CD40L surface mobilization we performed as previously described ^[@R37]^. Briefly, cells were blocked with anti-FcγRII/III antibody, and 10 μg/mL APC-labeled anti-CD40L was introduced into the cell culture immediately before stimulation PMA (50ng/mL) and ionomycin (1μg/mL) (Sigma-Aldrich), and then incubated for 30 minutes at 37°C. After 3 washes, cells were surface stained to identify subsets of CD4^+^ T cells.

Microscopy {#S15}
----------

Spleens were snap frozen in OCT tissue-freezing solution and stored at −80°C. Tissues were cut into 8μm sections and processed as described previously ^[@R52]^. Reagents used to stain sections are listed in **[Supplementary Table 2](#SD2){ref-type="supplementary-material"}**. Images were obtained from a laser-scanning confocal microscope (Model 510 META; Carl Zeiss) at 25x magnification. ImageJ software from the National Institutes of Health was used for the measurement of GC and B cell follicle size, distance measurements, and for T cell counting. The latter analyses were performed by in a blinded manner. The distance from GC T~FH~ cells to the dark zone (DZ) centers was normalized to the equivalent radius of the DZ.

Transwell Migration Assays {#S16}
--------------------------

Chemotaxis assays were performed as described previously ^[@R53]^. 5×10^5^ enriched CD4 splenic T cells were incubated for 1 h with 1× DMEM containing 0.5% fatty acid--free BSA (EMD Biosciences), 5% antibiotics, L-glutamine (Cellgro), and Hepes. Cells were then allowed to migrate through 5-μm-pore--sized transwells (Corning) toward soluble CXCL12, CXLC13 (R&D Systems) or media alone, for 3 h at 37°C. Cells were collected, stained, and resuspended in 45 μl of staining buffer and analyzed by flow cytometry.

ELISPOT for Total Immunoglobulins {#S17}
---------------------------------

Splenocytes from mice infected with *N. brasiliensis* were harvested, analyzed by flow cytometry to determine B cell numbers (anti-CD19), and plated (1×10^5^ cells/well) in quadruplicate on MultiScreen HTS plates (Millipore) coated with rat IgG anti-mouse light chain Abs, NP~6~-BSA, or NP~33~-BSA (Biosearch Technologies, 20 μg/ml). Antibodies used are listed in **[Supplementary Table 2](#SD2){ref-type="supplementary-material"}**. Spots were developed with Vector Blue (Vector Laboratories), and quantified using an ImmunoSpot analyzer (Cellular Technology Limited).

Cytokine ELISPOT Assays {#S18}
-----------------------

MultiScreen HTS plates were coated overnight at 4°C with anti-IL-21 and/or anti-IL-4 (eBioscience). Sorted cells were cultured (0.25 × 10^5^ cells/well) with PMA (50ng/mL) and ionomycin (1μg/mL) for 36 h at 37°C followed by adding primary then secondary detection antibodies (**[Supplementary Table 2](#SD2){ref-type="supplementary-material"})**. Spots were developed with Vector Blue (Vector Laboratories) and AEC (BD Biosciences). Spots were quantified using an ImmunoSpot analyzer (Cellular Technology Limited).

Sequence Analysis of the *Vh186.2* Heavy Chain Ig Gene of NP-specific GC B Cells {#S19}
--------------------------------------------------------------------------------

GC B cells were harvested from spleens of recipient mice 13 days post infection. PCR was performed as previously described ^[@R54]^. Briefly, the cDNA mixture was processed through two separate sets of the PCR reactions using Phusion high-fidelity Taq (0.02 U/μl/reaction) (Finnzymes). PCR products were cloned by zero blunt TOPO cloning (Invitrogen) and DNA sequence analysis was carried out on an Applied Biosystems 3730 capillary instrument.

RNA-Seq and Analysis {#S20}
--------------------

T~FH~ populations were sorted by flow cytometry. Two separate sorts were performed on different days, pooling spleens of 25-30 mice each day. Quality verification, library preparation, and sequencing were performed at the Yale Center for Genomic Analysis. Samples were sequenced on an Illumina HiSeq 2000 using 75-bp paired end reads. Reads were aligned to the mm9 mouse genome using TopHat version 2.0.6 and Bowtie version 1.3.0, and differential expression computed with Cufflinks version 2.0.2 ^[@R55]^. Analysis of RNA-seq data was done using the CummeRbund package version 2.0.0 in R. Differentially expressed genes were filtered by keeping transcripts with at least 1 read from each population significant at FDR-adjusted *p*-value \< 0.05 between 2 of the populations, and Fragments Per Kilobase of transcript per Million mapped reads (FPKM) were summed across isoforms to obtain data for 1300 significant genes. Clustering was done using either hierarchical clustering in R by the "average" method or the partitioning around medoids method with an arbitrary value of k=4, and Jensen-Shannon distance metrics. For heatmaps, expression values were normalized per gene.

Statistics {#S21}
----------

Data were analyzed using the Student\'s *t*-test or Fisher\'s exact test with Prism 6 (GraphPad Software). The number of asterisks represents the degree of significance with respect to *p* value, with the exact value presented within each figure legend.
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![*Il21*-Kat^+^*Il4*-GFP^−^ T~FH~ cells transition to *Il21*-Kat^−^*Il4*-GFP^+^ T~FH~ cells upon *N. brasiliensis* infection of *Il21*^Kat/+^*Il4*^GFP/+^ mice. (**a**) Flow cytometry of CD4^+^CD44^hi^ splenocytes from *Il21*^Kat/+^*Il4*^GFP/+^ mice, showing CXCR5^hi^PD-1^hi^ T~FH~ (green), CXCR5^int^PD-1^int^ (blue), and CXCR5^lo^PD-1^lo^ T~H~2 (red) cells. (**b**) Flow cytometry of GFP (*Il4*) and Kat (*Il21*) reporter-expressing cells, gated as **a**. (**c**) Quantification of T~FH~ cells. (**d**) Confocal microscopy of GCs from *Il21*^Kat/+^*Il4*^GFP/+^ mice 7 days post-infection, stained with anti-GFP (green), -CD4 (blue), -Turbo635 (red), and -IgD (white) (left 2 images); anti-GFP (green), -CD4 (blue), and -Turbo635 (red) (third image from left); and anti-CD4 (blue) and -Turbo635 (red) (far right image). Green, yellow, and red arrows indicate *Il21^−^Il4^+^* (Kat^−^GFP^+^), *Il21^+^Il4^+^* (Kat^+^GFP^+^), and *Il21^+^Il4^−^* (Kat^+^GFP^−^) CD4^+^ cells, respectively. (**e**) Flow cytometry of CellTrace Violet labeled donor CD4^+^Thy1.2^+^ *Il21*^Kat/+^*Il4*^GFP/+^ OT-II cells in Thy1.1 recipient spleens at 5 days post-infection and NP-OVA administration. Histogram showing dividing (shaded) and undivided (open; unimmunized control) donor cells (upper left) and summary of fraction of cytokine^+^ CXCR5^+^ cells among total T~FH~ cells (lower left). (**f**) Dual-color ELISPOTs of sorted reporter^+^ T~FH~ cells 8 days post-infection (as in **b**). Representative ELISPOTs (left) and total number of counted IL-21^+^ (blue), IL-4^+^ (red), and IL-21^+^IL-4^+^ spots (purple) for each T~FH~ cell population (right). \**P* \< 0.05; \*\**P* \< 0.01; \*\*\**P* \< 0.001 (Student\'s *t*-test). Error bars represent standard error of the mean (SEM). Data are from one experiment representative of three independent experiments with similar results, with three or four (**a,b**), three or five (**c**), or three (**f**) mice per group.](nihms-809301-f0001){#F1}

![*Il21* and *Il4* expression define transcriptionally distinct populations of T~FH~ cells. (**a**) Heatmap of significantly (*q* \< 0.05) differentially expressed genes (rows) in the four populations of cytokine expressing T~FH~ cells (columns). Light blue: cluster 1; magenta: cluster 2; light brown: cluster 3; green: cluster 4. (**b**) Heatmap of selected T cell-related genes. (**c**) Quantitative RT-PCR validation of selected genes, normalized to *Hprt*. (**d**) Flow cytometric quantification of geometric mean fluorescence intensity (gMFI) for CXCR5 and PD-1 expression from each T~FH~ cell population. \* *q* \< 0.05 (False discovery rate (FDR)-adjusted, comparing T~FH~21 and T~FH~4 cells, **b**) and \**P* \< 0.05 (**c**, **d**); \*\**P* \< 0.01; \*\*\**P* \< 0.001 (Student\'s *t*-test, **c**-**d**). Error bars represent SEM. FPKM: Fragments Per Kilobase of transcript per Million mapped reads. Analysis utilizes data from two independent experiment with 25 and 30 mice each (**a**-**b**), is representative of two independent (of each other and of **a**-**b**) experiments performed in technical triplicates with 15 and 20 mice each (**c**), or is from one experiment representative of three independent experiments with four mice per group (**d**).](nihms-809301-f0002){#F2}

![T~FH~21 and T~FH~4 cells differentially localize in the GC with distinctive expression of CXCR4 and CD40L. (**a**) Flow cytometric quantification of CXCR4 expression in T~FH~ cell populations and naïve CD4^+^ T cells. (**b**) Confocal microscopy of splenic GCs from *Il21*^Kat/+^*Il4*^GFP/+^ mice 10 days post-infection with *N. brasiliensis*, stained with anti-IgD (white), -CD35 (blue), -Turbo635 (red) and -GFP (green). (**c**) Migration assay measuring ratio of migrating to total T~FH~ cell subsets from *Il21*^Kat/+^*Il4*^GFP/+^ mice 8 days post-infection, co-cultured with CXCL12, CXCL13, or media, (**d**) Flow cytometric quantification of CD40L in T~FH~ cell subsets. \**P*\< 0.05, \*\**P* \< 0.01; \*\*\**P* \< 0.001 (Student\'s *t*-test, **a**,**c**,**d**). Error bars represent SEM. Data are from one experiment representative of three independent experiments (**b**-**d**), with seven (**a**), four (**b**), six (**c**), or eight (**d**) mice per group.](nihms-809301-f0003){#F3}

![T~FH~ cells modulate cytokine production after helminth infection. Flow cytometry (**a** , **b**) and dual-color IL-21 and IL-4 ELISPOT assays (**c**) of donor Thy1.2^+^ T~FH~ cells from *Il21*^Kat/+^*Il4*^GFP/+^ mice at 8 days post-infection with *N. brasiliensis*, transferred into Thy1.1^+^ Stg recipient mice and re-infected. \**P* \< 0.05 \*\**P* \< 0.01 (Student\'s *t*-test, **b**,**c**). Error bars represent SEM. N.D.: not detected. Data are from one experiment representative of three independent experiments, with three mice per group.](nihms-809301-f0004){#F4}

![T~FH~ cells transferred to Stg recipients five days after *N. brasiliensis* infection primarily become T~FH~4 cells upon reinfection. (**a**, **b**) Flow cytometry of splenic donor Thy1.2^+^ T~FH~ cells at 5 days after infection of Thy1.2^+^ (Thy1.1^−^) *Il21*^Kat/+^*Il4*^GFP/+^ mice, before transfer into Thy1.1^+^ Stg recipients. (**c**) Flow cytometry of donor CD4^+^Thy1.1^−^ T~FH~ cells at 13 days after secondary infection of Thy1.1^+^ Stg recipients. (**d**) Flow cytometry measuring GFP (*Il4*) and Kat (*Il21*) expression in donor T~FH~ cells from recipient spleens 13 days following infection (left) with percentages among donor cells (right). \*\**P*\< 0.01; \*\*\**P* \< 0.001 (Student\'s *t*-test, **d**). Error bars represent SEM. Data are from one experiment representative of three independent experiments, with four mice per group.](nihms-809301-f0005){#F5}

![Distinct T~FH~ cell populations differentially regulate the GC response. (**a**) Flow cytometry of splenic CD4^−^B220^+^IgD^lo^CD95^+^GL-7^+^ GC B cells in Stg recipients at 13 days after transfer of indicated T~FH~ cells from mice infected 8 days prior with *N. brasiliensis.* (**b**) Confocal microscopy of representative splenic follicles stained with anti-IgD (white) and PNA (blue). (**c**) Intracellular flow cytometry of IgG1 in GC B cells as in (**a**). (**d**) ELISPOT assays of splenic IgG1 (top left) or IgE antibody-secreting cells (ASCs, top right) among sorted B220^+^ B cells as in (**a**). (**e**) ELISA of Anti-*N. brasiliensis* IgG1 (left), IgE (middle), and IgM (right) in sera of recipient mice. \**P* \< 0.05; \*\**P* \< 0.01; \*\*\**P* \< 0.001 (Student\'s *t*-test). Error bars represent SEM. Data are from one experiment representative of three independent experiments, with four mice per group.](nihms-809301-f0006){#F6}

![T~FH~21 cells promote development of higher affinity GC B cells compared to T~FH~4 cells. (**a**) Total mutations (framework and complementary determining regions), and (**b**) tryptophan (W) to leucine (L) point mutations at position 33, of the V~H~186.2 gene in sequences cloned from sorted and pooled GC B cells 13 days after administration of *N. brasiliensis* and NP-OVA with boosting to mice receiving transferred *Il21*^Kat/+^*Il4*^GFP/+^ OT-II^+^ TCR transgenic T~FH~ cells (from mice infected 8 days prior with *N. brasiliensis* and NP-OVA; refer to **[Supplementary Fig. 7f](#SD1){ref-type="supplementary-material"}**) (**c**) ELISPOT assays of low (top) and high (bottom) affinity anti-NP^+^ IgG1^+^, IgE^+^, or IgG2a^+^ ASCs. (**e**) Intracellular Bcl-6 staining and (**f**) quantitative RT-PCR for *Prdm1* expression in recipient CD4−B220^+^IgD^lo^CD95^+^GL-7^+^ GC B cells after T~FH~-cell transfer and secondary infection (as in **a**). \**P* \< 0.05; \*\**P* \< 0.01; \*\*\**P* \< 0.001 (Fisher\'s exact test (**b**) and Student\'s *t*-test (**c**-**e**). Error bars represent SEM. Data are from one experiment representative of three independent experiments, with four mice per group.](nihms-809301-f0007){#F7}
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